Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05849857 |
|---|---|
| Brief Title: | Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries (MERLIN) |
| First Submitted : | March 22, 2023 |
| First Submitted that Met QC Criteria : | May 8, 2023 |
| First Posted : | May 9, 2023 |
| Last Update Submitted that Met QC Criteria : | October 31, 2023 |
| Last Update Posted : | November 1, 2023 |